![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/40 | (2006.01) |
C07D 403/06 | (2013.01) | ||
A61K 31/167 | (2006.01) | ||
C07D 513/04 | (2013.01) | ||
A61K 31/395 | (2006.01) | ||
C07D 403/14 | (2013.01) | ||
C07D 401/14 | (2006.01) | ||
C07D 401/14 | (2013.01) | ||
C07D 403/14 | (2006.01) | ||
C07D 471/04 | (2013.01) | ||
C07D 471/04 | (2006.01) | ||
C07D 417/14 | (2013.01) | ||
C07D 413/14 | (2013.01) | ||
C07D 487/04 | (2013.01) | ||
C07D 405/14 | (2013.01) | ||
C07D 409/14 | (2013.01) | ||
C07D 495/04 | (2013.01) | ||
C07D 493/04 | (2013.01) | ||
A61P 1/16 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 13/00 | (2018.01) | ||
A61P 13/02 | (2018.01) | ||
A61P 17/00 | (2018.01) | ||
A61P 19/02 | (2018.01) | ||
A61P 21/00 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 25/02 | (2018.01) | ||
A61P 27/00 | (2018.01) | ||
A61P 27/02 | (2018.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 3/06 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 9/00 | (2018.01) | ||
A61P 9/10 | (2018.01) | ||
Y02A 50/30 | (2018.01) |
(11) | Number of the document | 3340981 |
(13) | Kind of document | T |
(96) | European patent application number | 16840121.4 |
Date of filing the European patent application | 2016-08-25 | |
(97) | Date of publication of the European application | 2018-07-04 |
(45) | Date of publication and mention of the grant of the patent | 2022-10-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/048696 |
Date | 2016-08-25 |
(87) | Number | WO 2017/035353 |
Date | 2017-03-02 |
(30) | Number | Date | Country code |
201562209972 P | 2015-08-26 | US |
(72) |
WILES, Jason, Allan , US
PHADKE, Avinash, S. , US
DESHPANDE, Milind , US
AGARWAL, Atul , US
CHEN, Dawei , US
GADHACHANDA, Venkat, Rao , US
HASHIMOTO, Akihiro , US
PAIS, Godwin , US
WANG, Qiuping , US
WANG, Xiangzhu , US
|
(73) |
Achillion Pharmaceuticals, Inc. ,
121 Seaport Blvd., Boston, MA 02210,
US
|
(54) | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS |
ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS |